3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Vipoma
4
Carcinoma, Islet Cell
4
Somatostatinoma
3
Neuroendocrine Tumors
3
Intestinal Obstruction
3
Insulinoma
3
Glucagonoma
3
Gastrinoma
3
Carcinoma, Hepatocellular
3
Thymoma
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Meningioma
2
Diarrhea
2
Carcinoma
2
Carcinoid Tumor
2
Adenoma, Islet Cell
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Vomiting
1
Recurrence
1
Rectal Neoplasms
1
Primary Inoperable Thymoma
1
Pleural Effusion
1
Pheochromocytoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
anamorelin
2
Mirtazapine
2
Tirzepatide
1
Olanzapine
1
Octreotide
1
Nutritionists
1
Nutrition Assessment
1
Flurandrenolone
1
Exercise
1
EOM613
1
Diet, Carbohydrate-Restricted
1
Diet
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Weight Loss
×
Octreotide
×
Clear all
NCT04871204
2024-10-31
OTIS
Karolinska University Hospital
Phase 2
Completed
20 enrolled